Eli Lilly and Company (NYSE:LLY) is looking for bolt-on acquisitions. Anat Ashkenazi, Chief Financial Officer said, "We will continue to leverage bolt-on acquisitions and licensing opportunities to augment our future growth prospects with external innovation".
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
787 USD | +3.02% | +1.55% | +35.01% |
09:25am | Roche shares gain on obesity drug results from early-stage trial | RE |
06:41am | US Senate Committee Warns of Potential Healthcare Bankruptcy Due to Novo Nordisk's Wegovy | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+35.01% | 709B | |
+31.07% | 595B | |
-2.60% | 367B | |
+20.83% | 334B | |
+5.69% | 289B | |
+14.48% | 239B | |
+9.32% | 211B | |
-3.44% | 203B | |
+10.77% | 171B | |
+0.10% | 163B |
- Stock Market
- Equities
- LLY Stock
- News Eli Lilly and Company
- Eli Lilly Seeks Bolt-On Acquisitions